mhurhangee/ep-ind-claims huggingface dataset:
A method for obtaining group information by a second PoC client in a Push-to-Talk over Cellular, PoC, session, comprising: initiating, by a first PoC client, a PoC Ad hoc session; receiving, by a PoC server, a session request message carrying information about the first PoC client initiating the Ad hoc session and session group member information from the first PoC client; sending, by the PoC server, the session request message carrying the session group member information to a participating function server; receiving, by the participating function server, the session request message carrying the session group member information; when determining to send the session group member information to the second PoC client according to an answer mode of the second PoC client and supplementary information of the session request message, sending, by the participating function server the session group member information to the second PoC client; and when determining not to send the session group member information to the second PoC client according to the answer mode of the second PoC client and supplementary information of the session request message, deleting the session group member information, then sending by the participating function server the session request message to the second PoC client. initiating, by a first PoC client, a PoC Ad hoc session; receiving, by a PoC server, a session request message carrying information about the first PoC client initiating the Ad hoc session and session group member information from the first PoC client; sending, by the PoC server, the session request message carrying the session group member information to a participating function server; receiving, by the participating function server, the session request message carrying the session group member information; when determining to send the session group member information to the second PoC client according to an answer mode of the second PoC client and supplementary information of the session request message, sending, by the participating function server the session group member information to the second PoC client; and when determining not to send the session group member information to the second PoC client according to the answer mode of the second PoC client and supplementary information of the session request message, deleting the session group member information, then sending by the participating function server the session request message to the second PoC client.
A compound of formula I': or a pharmaceutically acceptable salt thereof, wherein: Ring A is wherein Ring A is optionally substituted with 1-4 groups selected from fluorine, -CN, -OR, or C 1-6 aliphatic optionally substituted with 1-3 fluorine atoms; Ring B is R 1 is hydrogen, -CN, -OR, or C 1-6 aliphatic optionally substituted with 1-4 groups selected from fluorine, -CN, or -OR; R 2 is hydrogen or C 1-10 aliphatic optionally substituted with 1-5 groups selected from fluorine, -CN, or -OR; each of X 1 and X 2 represent CH; R 3 is halogen, -CN, -R, or -OR; each R 4 is independently halogen, -CN, -R, or -OR; R 5 is hydrogen or halogen; n is 0-4; and each R is independently hydrogen or C 1-6 aliphatic optionally substituted with 1-3 fluorine atoms with the proviso that (3-amino-5-hydroxypiperidin-1-yl)(2-(1-ethyl-1H-indol-2-yl)-1-methyl-1H-benzo[d]imidazol-5-yl)methanone hydrochloride is excluded. Ring A is wherein Ring A is optionally substituted with 1-4 groups selected from fluorine, -CN, -OR, or C 1-6 aliphatic optionally substituted with 1-3 fluorine atoms; Ring B is R 1 is hydrogen, -CN, -OR, or C 1-6 aliphatic optionally substituted with 1-4 groups selected from fluorine, -CN, or -OR; R 2 is hydrogen or C 1-10 aliphatic optionally substituted with 1-5 groups selected from fluorine, -CN, or -OR; each of X 1 and X 2 represent CH; R 3 is halogen, -CN, -R, or -OR; each R 4 is independently halogen, -CN, -R, or -OR; R 5 is hydrogen or halogen; n is 0-4; and each R is independently hydrogen or C 1-6 aliphatic optionally substituted with 1-3 fluorine atoms with the proviso that (3-amino-5-hydroxypiperidin-1-yl)(2-(1-ethyl-1H-indol-2-yl)-1-methyl-1H-benzo[d]imidazol-5-yl)methanone hydrochloride is excluded.
A nickel-based alloy composition consisting, in weight percent, of: between 12.3 and 15.2% chromium, between 4.8 and 12.0% cobalt, between 2.5 and 8.3% tungsten, between 0.0 and 0.5% molybdenum, between 0.0 and 0.5% rhenium, between 3.5 and 6.7% aluminium, between 6.1 and 10.7% tantalum, between 0.0 and up to 0.5% hafnium, between 0.0 and 0.5% niobium, between 0.0 and 0.5% titanium, between 0.0 and 0.5% vanadium, between 0.0 and 0.1% silicon, between 0.0 and 0.1% yttrium, between 0.0 and 0.1% lanthanum, between 0.0 and 0.1% cerium, between 0.0 and 0.003% sulphur, between 0.0 and 0.05% manganese, between 0.0 and 0.05% zirconium, between 0.0 and 0.005% boron, between 0.0 and 0.01% carbon, the balance being nickel and incidental impurities.
A method for predicting a subject's responsiveness to an anti-angiogenic therapeutic agent comprising: measuring expression levels of a biomarker panel from a test cancer tissue sample obtained from a subject, wherein the biomarker panel comprises: a) IGF2 and at least one or more additional biomarkers selected from Table 2C, wherein the one additional biomarker is not C21orf63, ISLR, MIR198, SLC5A1 or SNORD114-14; or b) IGF2 and at least two or more additional biomarkers selected from Table 2C; wherein the biomarker panel does not consist of the 631 biomarkers shown in Table 1B of WO 2012/167278; determining a sample expression score for the biomarker panel; comparing the sample expression score to a threshold score; and classifying the subject as responsive or non-responsive to the anti-angiogenic therapeutic agent based on whether the sample expression score is above or below the threshold expression score. measuring expression levels of a biomarker panel from a test cancer tissue sample obtained from a subject, wherein the biomarker panel comprises: a) IGF2 and at least one or more additional biomarkers selected from Table 2C, wherein the one additional biomarker is not C21orf63, ISLR, MIR198, SLC5A1 or SNORD114-14; or b) IGF2 and at least two or more additional biomarkers selected from Table 2C; wherein the biomarker panel does not consist of the 631 biomarkers shown in Table 1B of WO 2012/167278; a) IGF2 and at least one or more additional biomarkers selected from Table 2C, wherein the one additional biomarker is not C21orf63, ISLR, MIR198, SLC5A1 or SNORD114-14; or b) IGF2 and at least two or more additional biomarkers selected from Table 2C; wherein the biomarker panel does not consist of the 631 biomarkers shown in Table 1B of WO 2012/167278; determining a sample expression score for the biomarker panel; comparing the sample expression score to a threshold score; and classifying the subject as responsive or non-responsive to the anti-angiogenic therapeutic agent based on whether the sample expression score is above or below the threshold expression score.
A reproduction device comprising: a variable speed reproduction processing unit configured to perform variable speed reproduction processing to a multiplexed stream including a subtitle stream configured by a video stream configured by a video packet having encoded image data in a payload, and a subtitle packet that has subtitle information in a payload and in which subtitle display priority information, a display start time, and display end time of a subtitle according to the subtitle information are inserted; and a subtitle display control unit configured to control display of a subtitle according to subtitle information included in each subtitle packet on the basis of the priority information when variable speed reproduction processing is performed to the multiplexed stream by the variable speed reproduction processing unit, wherein the subtitle display control unit is configured to determine whether an interval between start times of a first subtitle and at least one subsequent second subtitle is smaller than a display period of the first subtitle, leading to an overlap period between the first and the at least one second subtitle, and if an overlap period occurs, to select, among the first and the second subtitles, the subtitle with the highest display priority as a subtitle to be displayed. a variable speed reproduction processing unit configured to perform variable speed reproduction processing to a multiplexed stream including a subtitle stream configured by a video stream configured by a video packet having encoded image data in a payload, and a subtitle packet that has subtitle information in a payload and in which subtitle display priority information, a display start time, and display end time of a subtitle according to the subtitle information are inserted; and a subtitle display control unit configured to control display of a subtitle according to subtitle information included in each subtitle packet on the basis of the priority information when variable speed reproduction processing is performed to the multiplexed stream by the variable speed reproduction processing unit, wherein the subtitle display control unit is configured to determine whether an interval between start times of a first subtitle and at least one subsequent second subtitle is smaller than a display period of the first subtitle, leading to an overlap period between the first and the at least one second subtitle, and if an overlap period occurs, to select, among the first and the second subtitles, the subtitle with the highest display priority as a subtitle to be displayed.
A method for displaying images during ophthalmic surgery, the method comprising: displaying a left analog image in a left ocular (126-L) of a surgical microscope, wherein the left analog image is of an objective field of the surgical microscope; displaying a right analog image in a right ocular (126-R) of the surgical microscope, wherein the right analog image is of the objective field; generating a left digital image and a right digital image, wherein the left digital image and the right digital image include overlay content for display with the left analog image and the right analog image, respectively; receiving from a user a first indication of a location-dependent feature in the overlay content, chracterized in that the location-dependent feature exhibits a parallax; and responsive to the first indication, displaying the location-dependent feature in only one of the left digital image and the right digital image and not in the other of the left digital image and the right digital image to avoid the parallax. displaying a left analog image in a left ocular (126-L) of a surgical microscope, wherein the left analog image is of an objective field of the surgical microscope; displaying a right analog image in a right ocular (126-R) of the surgical microscope, wherein the right analog image is of the objective field; generating a left digital image and a right digital image, wherein the left digital image and the right digital image include overlay content for display with the left analog image and the right analog image, respectively; receiving from a user a first indication of a location-dependent feature in the overlay content, chracterized in that the location-dependent feature exhibits a parallax; and responsive to the first indication, displaying the location-dependent feature in only one of the left digital image and the right digital image and not in the other of the left digital image and the right digital image to avoid the parallax.
Implant for adjusting the position of at least one tissue holder for soft tissue, whereby this implant presents a base with drill holes through which screws can be fixed in a patient's bone tissue so as to fasten the implant to bone tissue at a distance from said tissue holder, wherein the implant has a guide for an elongate pulling member, this pulling member being connected to said tissue holder, and whereby the implant includes a fixing element which can be moved between a fixing position in which the pulling member is clamped by the fixing element and a free position in which said pulling member can freely move through said guide, characterised in that said fixing element cooperates with a control element which makes it possible to move this fixing element between said fixing position and said free position when the implant is attached to said bone tissue and when the implant is covered with soft tissue such as muscle tissue or skin tissue, wherein said implant comprises a clamping element formed of a wall extending opposite said fixing element and practically vertically in relation to said base, whereby said pulling member extends between said clamping element and the fixing element, such that in said fixing position, the pulling member is clamped between the fixing element and the clamping element, and in said free position, the pulling member can be moved according to its longitudinal direction between the fixing element and the clamping element,.
A method of making a paint or an ink, comprising a hollow polymer composition, the method comprising the steps of (a) providing an aqueous dispersion comprising (i) 1% to 40% hollow polymer particles, by weight based on the weight of the aqueous dispersion, wherein the hollow polymer particles comprise 0.01% to 20% polymerized units of one or more multivinyl monomer, by weight based on the weight of the hollow polymer particles, (ii) 40% to 98.9% water, by weight based on the weight of the aqueous dispersion, and (iii) 0.1% to 20% one or more organic alcohol, by weight based on the weight of the aqueous dispersion, and (b) removing water from the aqueous dispersion to form a dry composition comprising the hollow polymer particles and the alcohol, wherein either water is absent from the dry composition or else water is present in the dry composition in an amount such that the weight ratio of water to hollow polymer particles is 0.2:1 or less, and (c) after step (b), forming a dispersion of the dry composition in a non-aqueous medium. (a) providing an aqueous dispersion comprising (i) 1% to 40% hollow polymer particles, by weight based on the weight of the aqueous dispersion, wherein the hollow polymer particles comprise 0.01% to 20% polymerized units of one or more multivinyl monomer, by weight based on the weight of the hollow polymer particles, (ii) 40% to 98.9% water, by weight based on the weight of the aqueous dispersion, and (iii) 0.1% to 20% one or more organic alcohol, by weight based on the weight of the aqueous dispersion, and (i) 1% to 40% hollow polymer particles, by weight based on the weight of the aqueous dispersion, wherein the hollow polymer particles comprise 0.01% to 20% polymerized units of one or more multivinyl monomer, by weight based on the weight of the hollow polymer particles, (ii) 40% to 98.9% water, by weight based on the weight of the aqueous dispersion, and (iii) 0.1% to 20% one or more organic alcohol, by weight based on the weight of the aqueous dispersion, and (b) removing water from the aqueous dispersion to form a dry composition comprising the hollow polymer particles and the alcohol, wherein either water is absent from the dry composition or else water is present in the dry composition in an amount such that the weight ratio of water to hollow polymer particles is 0.2:1 or less, and (c) after step (b), forming a dispersion of the dry composition in a non-aqueous medium.
A hotmelt adhesive composition comprising, based on the total weight of the composition: (i) 15 to 45% by weight of at least one tackifying resin, and (ii) 20 to 60% by weight of a mixture of at least one single-site catalyzed propylene homopolymer and at least one propylene copolymer, wherein the propylene homopolymer has a weight average molecular weight of 20,000 to 145,000, the propylene copolymer has an ethylene comonomer content of 5 to 25% by weight, and the weight ratio of propylene homopolymer to propylene copolymer is from 1:3 to 3:1, wherein the hotmelt adhesive further comprises (iii) at least one of the following two components (a) and (b): (a) a particulate phosphorous based compound in an amount of 15 to 40% by weight, or (b) an at a temperature of 20°C liquid phosphorous based compound in an amount of 4 to 15% by weight. (i) 15 to 45% by weight of at least one tackifying resin, and (ii) 20 to 60% by weight of a mixture of at least one single-site catalyzed propylene homopolymer and at least one propylene copolymer, wherein the propylene homopolymer has a weight average molecular weight of 20,000 to 145,000, the propylene copolymer has an ethylene comonomer content of 5 to 25% by weight, and the weight ratio of propylene homopolymer to propylene copolymer is from 1:3 to 3:1, wherein the hotmelt adhesive further comprises the propylene homopolymer has a weight average molecular weight of 20,000 to 145,000, the propylene copolymer has an ethylene comonomer content of 5 to 25% by weight, and the weight ratio of propylene homopolymer to propylene copolymer is from 1:3 to 3:1, (iii) at least one of the following two components (a) and (b): (a) a particulate phosphorous based compound in an amount of 15 to 40% by weight, or (b) an at a temperature of 20°C liquid phosphorous based compound in an amount of 4 to 15% by weight. (a) a particulate phosphorous based compound in an amount of 15 to 40% by weight, or (b) an at a temperature of 20°C liquid phosphorous based compound in an amount of 4 to 15% by weight.
Computer-implemented method for generating a magnetic resonance image dataset, comprising the steps: - providing a raw dataset, wherein the raw dataset has been acquired such that it is spatially and/or temporally undersampled, - providing measurement signals of a phase correction measurement, - determining a regularisation parameter (λ) in an automated manner, and - generating an image dataset from the raw dataset using the regularisation parameter (λ) in a compressed sensing technique, characterised in that - the regularisation parameter (λ) is determined from at least two echo signals (14a, 14b, 14c, 14d, 14e), wherein the echo signals from the measurement signals of the phase correction measurement are used, - the raw dataset and the phase correction measurement are acquired with the aid of a TSE sequence. - providing a raw dataset, wherein the raw dataset has been acquired such that it is spatially and/or temporally undersampled, - providing measurement signals of a phase correction measurement, - determining a regularisation parameter (λ) in an automated manner, and - generating an image dataset from the raw dataset using the regularisation parameter (λ) in a compressed sensing technique, characterised in that - the regularisation parameter (λ) is determined from at least two echo signals (14a, 14b, 14c, 14d, 14e), wherein the echo signals from the measurement signals of the phase correction measurement are used, - the raw dataset and the phase correction measurement are acquired with the aid of a TSE sequence.
An internal combustion engine with external mixture formation, comprising: at least one exhaust tract and at least one intake tract, wherein the intake tract has at least one intake pipe, at least one throttling valve, at least one mixture formation device, at least one compensation vessel and at least one air filter, characterized in that the compensation vessel comprises a compensation vessel inlet and a compensation vessel outlet on one side of the compensation vessel and an outer surface of the compensation vessel opposite to the compensation vessel inlet and the compensation vessel outlet is designed in a step-shaped manner. at least one exhaust tract and at least one intake tract, wherein the intake tract has at least one intake pipe, at least one throttling valve, at least one mixture formation device, at least one compensation vessel and at least one air filter, characterized in that the compensation vessel comprises a compensation vessel inlet and a compensation vessel outlet on one side of the compensation vessel and an outer surface of the compensation vessel opposite to the compensation vessel inlet and the compensation vessel outlet is designed in a step-shaped manner.
Film comprising at least one layer (i) containing at least one blend of at least one or more poly- or copolycondensates of an aromatic and/or cycloalkyl-dicarboxylic acid and aliphatic, cycloaliphatic and/or araliphatic diols having 2 to 16 carbon atoms with one or more poly- or copolycarbonates, characterized in that the fraction of poly- or copolycarbonate(s) in this blend is situated in a range from ≥ 50 wt% to ≤ 90 wt%, and in that the poly- or copolycondensate(s) of an aromatic and/or cycloalkyl-dicarboxylic acid and aliphatic, cycloaliphatic and/or araliphatic diols having 2 to 16 carbon atoms has or have a fraction of 1,4-cyclohexanedimethanol, 1,3-cyclohexanedimethanol and/or 2,2,4,4-tetramethyl-1,3-cyclobutanediol in a range from ≥ 20 to ≤ 80 mol%, based on the diol component, with this at least one layer (i) containing at least one laser-sensitive additive, preferably a black pigment, more preferably carbon black, with the laser-sensitive additive, preferably a black pigment, more preferably carbon black, being present in an amount of 40 to 180 ppm, preferably of 50 to 160 ppm.
An X-ray detecting apparatus for the detection and localisation of ionising X-ray or gamma radiation in radiography, the apparatus comprising: an X-ray detector including conversion means for converting x-ray photons of an incident x-ray photon beam into electrical charges; and non-linear amplification means for amplifying, within the detector, the electrical charges by a non-linear amplification gain factor, said non-linear amplification gain factor being characterised by a decrease in amplification gain in response to an increase in the flux of the incident x-ray photon beam at high incident x-ray fluxes; and amplification gain adjustment means configured to vary the non-linear amplification gain of the non-linear amplification means according to the transmitted beam received by the detector from the x-ray source via the subject being imaged, the x-ray detecting apparatus being characterised in that the amplification gain adjustment means is configured to maximize the non-linearity of the amplification gain of the non-linear amplification means so that the low intensity part of the image corresponding to high x-ray attenuation by the subject is highly amplified while the high intensity part of the image corresponding to low x-ray attenuation by the subject is less amplified. an X-ray detector including conversion means for converting x-ray photons of an incident x-ray photon beam into electrical charges; and non-linear amplification means for amplifying, within the detector, the electrical charges by a non-linear amplification gain factor, said non-linear amplification gain factor being characterised by a decrease in amplification gain in response to an increase in the flux of the incident x-ray photon beam at high incident x-ray fluxes; and conversion means for converting x-ray photons of an incident x-ray photon beam into electrical charges; and non-linear amplification means for amplifying, within the detector, the electrical charges by a non-linear amplification gain factor, said non-linear amplification gain factor being characterised by a decrease in amplification gain in response to an increase in the flux of the incident x-ray photon beam at high incident x-ray fluxes; and amplification gain adjustment means configured to vary the non-linear amplification gain of the non-linear amplification means according to the transmitted beam received by the detector from the x-ray source via the subject being imaged, the x-ray detecting apparatus being characterised in that the amplification gain adjustment means is configured to maximize the non-linearity of the amplification gain of the non-linear amplification means so that the low intensity part of the image corresponding to high x-ray attenuation by the subject is highly amplified while the high intensity part of the image corresponding to low x-ray attenuation by the subject is less amplified.